알츠하이머 신약 개발 잇단 '실패' 쓴 맛 - 데일리메디
알츠하이머 신약 개발 잇단 '실패' 쓴 맛 - 데일리메디: 알츠하이머 치료제 개발에 세계 굴지의 제약사들이 잇단 실패의 쓴 맛을 보고 있다. 최근 릴리의 '솔라네주맵'부터 지난 9일 박스터의 '감마가드' ...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.